ReproCELL, Inc.

14
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3974770004
JPY
149.00
-3 (-1.97%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
ReproCELL, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
45.00
-28.00
-303.00
-573.00
-811.00
-1,015.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-224.00
-96.00
-22.00
114.00
46.00
11.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
6.00
-11.00
-140.00
-246.00
-648.00
-689.00
Cash Flow from Investing Activities
-795.00
404.00
-1,087.00
-2,144.00
-1,416.00
1,225.00
Cash Flow from Financing Activities
680.00
544.00
482.00
2,384.00
4.00
0.00
Net Cash Inflow / Outflow
-115.00
1,024.00
-722.00
35.00
-1,984.00
472.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-6.00
87.00
22.00
41.00
77.00
-61.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of ReproCELL, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Profit Before Tax
45.053
1326.515
-1,281.00
-96.60%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-224.606
-1087.942
863.00
79.35%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
6.28700000000001
2978.537
-2,972.00
-99.79%
Cash Flow from Investing Activities
-795.995
-4574.453
3,779.00
82.60%
Cash Flow from Financing Activities
680.11
-1127.753
1,807.00
160.31%
Net Cash Inflow / Outflow
-115.69
-2774.531
2,659.00
95.83%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-6.092
-50.862
44.00
88.02%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is 154.90% vs 91.85% in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
6.29
-11.45
154.90%